Richard Ferrari
Richard Ferrari's purchase track record
How the stock did after each of Richard Ferrari's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 4/16/2026 | BEAT | $50K | -29.0% | -46.7% | +10.0% |
| 2/14/2025 | BEAT | $50K | -27.2% | -51.6% | +5.5% |
| 11/8/2022 | LUNG | $29K | +73.1% | +136.9% | +7.6% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
Pulmonx Sets Q3 2026 Earnings Date for October 27. Pulmonx Corporation has announced that it will report its third-quarter 2026 financial results on October 27, 2026. This scheduled update provides a specific timeline for investors to review the company's latest performance metrics. The announcement serves as a standard corporate disclosure rather than a change in business operations.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 5, 2026
HeartBeam Receives FDA Breakthrough Designation for Heart Attack Test. HeartBeam Inc. announced that its Home Heart Attack Test system has been granted FDA Breakthrough Device designation. The designation recognizes the product’s potential to improve early detection of heart attacks at home. The company’s technology could expand its market presence and support future regulatory approvals. The news adds to the company’s positive momentum amid a mixed market session.
Transaction History
| TNON | ▲ Buy | Option Exercise | 64,479 | $0 | 7/31/2026 | View on chart |
| LUNG | ▲ Buy | Grant | 40,000 | $0 | 6/5/2026 | View on chart |
| BEAT | ▲ Buy | Open Market | 62,500 | $50K | 4/16/2026 | View on chart |
| BEAT | ▲ Buy | Grant | 50,000 | $0 | 2/9/2026 | View on chart |
| TNON | ▲ Buy | Option Exercise | 64,478 | $0 | 1/1/2026 | View on chart |
| LUNG | ▼ Sell | Open Market | 8,000 | $25K | 6/12/2025 | View on chart |
| LUNG | ▲ Buy | Grant | 37,153 | $0 | 6/2/2025 | View on chart |
| BEAT | ▲ Buy | Open Market | 29,412 | $50K | 2/14/2025 | View on chart |
| BEAT | ▲ Buy | Grant | 44,247 | $0 | 6/12/2024 | View on chart |
| LUNG | ▲ Buy | Grant | 15,216 | $0 | 6/3/2024 | View on chart |
| BEAT | ▲ Buy | Grant | 31,948 | $0 | 7/13/2023 | View on chart |
| LUNG | ▲ Buy | Grant | 12,620 | $0 | 6/1/2023 | View on chart |
| TNON | ▲ Buy | Option Exercise | 91,300 | $148K | 5/22/2023 | View on chart |
| LUNG | ▲ Buy | Open Market | 5,338 | $28K | 11/8/2022 | View on chart |
| LUNG | ▲ Buy | Open Market | 100 | $529 | 11/8/2022 | View on chart |
| BEAT | ▲ Buy | Grant | 73,529 | $0 | 7/15/2022 | View on chart |
| LUNG | ▲ Buy | Grant | 5,600 | $0 | 6/1/2022 | View on chart |
| BEAT | ▲ Buy | Option Exercise | 65,653 | $276K | 11/11/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 3, 2026
Tenon Medical launches Symmetry+ 3D printed screw
Tenon Medical announced the full commercial launch of its Symmetry+ SI Joint Fusion 3D printed lateral screw following a successful alpha launch. This marks a key step in the company's product rollout, expanding its commercial footprint in the orthopedic market. The news highlights the company's focus on titanium 3D-printed solutions for spinal and joint fusion procedures.
Tenon Medical launches Symmetry+ 3D printed screw. Tenon Medical announced the full commercial launch of its Symmetry+ SI Joint Fusion 3D printed lateral screw following a successful alpha launch. This marks a key step in the company's product rollout, expanding its commercial footprint in the orthopedic market. The news highlights the company's focus on titanium 3D-printed solutions for spinal and joint fusion procedures.